BioLife Solutions Inc (NAS:BLFS)

Q1 2025 BioLife Solutions Inc Earnings Call Transcript

May 8, 2025 / 08:30 PM GMT

Release Date Price: $22.36 (+4.78%)

Transcript 10-Q8-K

Key Points

Positve

BioLife Solutions Inc (BLFS) reported a strong start to 2025 with a 33% increase in cell processing revenue and a 30% increase in total revenue year over year.
The company has a fortified balance sheet with over $100 million in cash, providing a solid foundation for growth initiatives and market share expansion.
BioLife Solutions Inc (BLFS) has demonstrated success with customers adopting multiple components of their platform, enhancing revenue potential per dose.
The acquisition of Panthera Cryosolutions expands their biopreservation portfolio and scientific capabilities, aligning with their strategic growth initiatives.
The company reaffirmed its full-year revenue guidance, expecting total revenue between $95.5 million to $99 million, reflecting 16% to 20% growth.

Negative

Despite strong revenue growth, BioLife Solutions Inc (BLFS) reported a GAAP net loss of $400,000 for Q1 2025.
The company faces potential near-term uncertainties from tariffs, NIH funding cuts, and FDA leadership changes, which could impact the operating environment.
There is limited visibility into the customer segmentation of distributors, which could pose challenges in demand forecasting.
The integration of Panthera Cryosolutions is expected to incur approximately $1 million in R&D expenses for the remainder of 2025, with no material revenue expected from Panthera this year.
Switching costs for customers to adopt new biopreservation media are high, potentially limiting immediate revenue opportunities from the Panthera acquisition.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BLFS.OQ - Biolife Solutions Inc
Q1 2025 BioLife Solutions Inc Earnings Call
May 08, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon ladies and gentlemen, and thank you for standing by. Welcome to the Bioife Solutions first quarter 2025 shareholder and analyst conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session.

I will now turn the call over to Troy Wickerman, Chief Financial Officer of Biolife Solutions. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Good afternoon, everyone, and thank you for joining the Biolife Solutions 2025 1st quarter

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.